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Canonical Wnt signaling requires inhibition of
Glycogen Synthase Kinase 3 (GSK3) activity, but the
molecular mechanism by which this is achieved
remains unclear. Here, we report that Wnt signaling
triggers the sequestration of GSK3 from the cytosol
intomultivesicular bodies (MVBs), so that this enzyme
becomes separated from its many cytosolic
substrates. Endocytosed Wnt colocalized with GSK3
in acidic vesicles positive for endosomal markers.
After Wnt addition, endogenous GSK3 activity
decreased in the cytosol, and GSK3 became pro-
tected from protease treatment inside membrane-
bounded organelles. Cryoimmunoelectron micros-
copy showed that these corresponded to MVBs.
Two proteins essential for MVB formation, HRS/
Vps27 and Vps4, were required for Wnt signaling.
The sequestration of GSK3 extended the half-life of
many other proteins in addition to b-Catenin,
including an artificial Wnt-regulated reporter protein
containing GSK3 phosphorylation sites.We conclude
that multivesicular endosomes are essential compo-
nents of the Wnt signal-transduction pathway.
INTRODUCTION
Canonical Wnt signaling plays a crucial role in development,
tissue regeneration, stem cells, and cancer (Logan and Nusse,
2004; Clevers, 2006; MacDonald et al., 2009; Angers and
Moon, 2009). A cytoplasmic destruction complex consisting of
GlycogenSynthaseKinase 3 (GSK3,which hasa and b isoforms),
Casein Kinase 1 (CK1), Adenomatous Polyposis Coli (APC), and
Axin mediates the phosphorylation of b-Catenin. Phosphoryla-
tion targets b-Catenin for polyubiquitinylation and subsequent
degradation in proteasomes. In the presence of Wnt, the
destruction complex becomes inactivated in ways that are1136 Cell 143, 1136–1148, December 23, 2010 ª2010 Elsevier Inc.incompletely understood. Wnt triggers signaling by binding to
Frizzled and LDL-receptor related protein 6 (LRP6), causing the
aggregation of Dishevelled (Dvl) and Axin on the plasma
membrane (Bilic et al., 2007; Zeng et al., 2008). The key step in
the canonical pathway is the inactivation of GSK3, as evidenced
by the fact that pharmacological inhibition of this enzyme elicits
a typical Wnt signal. The molecular mechanism of GSK3
inhibition remains one of themain open questions in theWnt field
(Wu and Pan, 2010).
Internalization of receptor complexes is an absolute require-
ment for Wnt signaling (Blitzer and Nusse, 2006; Yamamoto
et al., 2006). Bilic et al. (2007) discovered that cytoplasmic
particles designated LRP6-signalosomes—containing aggre-
gates of phospho-LRP6, Frizzled, Dvl, Axin, and GSK3—are
formed at and under the plasma membrane 15 min after Wnt
addition. Activated Wnt receptors recruit Axin and GSK3, which
phosphorylates five critical PPPS/TP sequences in the intracel-
lular domain of LRP6 (Zeng et al., 2008; Niehrs and Shen,
2010). A number of mechanisms have been proposed to explain
the inhibition of GSK3 (Kimelman andXu, 2006). For example, the
LRP6 tail may act as a direct inhibitor of GSK3 (Mi et al., 2006;
Cselenyi et al., 2008; Piao et al., 2008; Wu et al., 2009). The
LRP6 PPPSP repeats serve both as substrates and binding sites
for GSK3 and may act as competitive inhibitors of this enzyme,
although at low affinity (Ki of 1.33 10
5 M; Cselenyi et al., 2008).
GSK3 has many substrates in addition to b-Catenin, including
Dvl, Axin, and APC (Jope and Johnson, 2004). This promiscuous
enzyme phosphorylates serine or threonine at position 4 of
sites primed by phosphorylation (S/TXXXS/T[PO3]) (Cohen and
Frame, 2001). We reported that the transcription factor Smad1
is polyubiquitinylated and degraded after GSK3 phosphorylation
and is stabilized by canonical Wnt signaling, resulting in the inte-
gration of BMP andWnt signaling (Fuentealba et al., 2007). Addi-
tional substrates destabilized by GSK3 phosphorylation have
since been identified (Kim et al., 2009).
During our investigations on signaling integration, we
measured GSK3 enzyme activity in Wnt-treated cell extracts
(prepared in the presence of Triton X-100) and were surprised
to find that Wnt did not change GSK3 activity (data not shown),
even though in the direct GSK3 inhibition model one would have
predicted inhibition. How could this be?Upon reflection, we real-
ized that following ligand binding and endocytosis, growth factor
receptors are incorporated into multivesicular endosomes within
15 min (Gruenberg and Stenmark, 2004). Multivesicular body
(MVB) formation is an obligatory step before degradation in lyso-
somes can take place (Katzmann et al., 2002). As first discovered
for EGF receptor, the topology is such that the cytoplasmic side
of the plasma membrane corresponds to the lumen of the small
MVB vesicles (McKanna et al., 1979). Therefore, Wnt-induced
MVB formation would cause GSK3 bound to phosphorylated
LRP6 cytoplasmic tails (and other GSK3 substrates such as
Axin, APC, b-Catenin, and Dvl) to become sequestered from its
cytosolic substrates by two layers of membrane (see model in
Figure 7), effectively inhibiting its activity.
In this study, we tested the GSK3 sequestration hypothesis of
Wnt signaling. Fluorescence microscopy showed that Wnt
signaling caused the relocalization of cytoplasmic GSK3 to vesi-
cles that colocalized with endocytosed xWnt8-Venus protein,
and with the MVB and lysosomal markers Rab7 and Lyso-
Tracker. Wnt signal transduction was blocked by depletion of
Hrs/Vps27 or expression of dominant-negative Vps4, two
proteins essential for intralumenal vesicle formation in MVBs
(Katzmann et al., 2002; Wollert and Hurley, 2010). Moreover,
Wnt treatment decreased cytosolic GSK3 activity levels
(measured in Digitonin-permeabilized cells), yet full enzyme
activity was recovered after solubilization of all membranes
with Triton X-100. Similarly, Wnt caused endogenous GSK3b
to become partially protected from Proteinase K digestion, but
only in the absence of Triton X-100. Finally, cryoimmunoelectron
microscopy showed that GSK3 was indeed translocated from
the cytosol into MVBs after Wnt pathway activation. Bioinfor-
matic analyses revealed that 20% of the human proteome
contains multiple putative GSK3 phosphorylation sites. Total
protein half-life was extended by Wnt treatment or GSK3 inhibi-
tion. The addition of GSK3 phosphorylation sites was sufficient
to place the stability of a Green Fluorescent Protein (GFP)
biosensor under the control of Wnt. We conclude that canonical
Wnt signaling sequesters GSK3 inside MVBs, reducing its cyto-
solic levels and extending the half-life of many GSK3 substrates.
RESULTS
Wnt Causes GSK3 Relocalization in Acidic Cytoplasmic
Vesicles
We first asked whether Wnt treatment changed the subcellular
localization of GSK3. Human 293T cells expressing xWnt8-
Venus (Mii and Taira, 2009) were cultured together with mouse
3T3 cells transfected with GSK3-RFP. Remarkably, endocy-
tosed Wnt-Venus and GSK3-RFP accumulated in the same
vesicular structures (arrows in Figure 1F), while GSK3-RFP levels
decreased in the cytosol (Figures 1A–1F). Relocalization of
endogenous GSK3b was also observed in these cocultures
(Figures S1A–S1C available online). Wnt-Venus puncta were
counted in each responding cell (n = 80), and 56% ± 9% of
them colocalized with GSK3-RFP puncta (see histogram in Fig-
ure 1C0). Thus, cytosolic GSK3 decreases and becomes relocal-
ized to the same endosomes as the internalized Wnt ligand.CTransfection of constitutively active LRP6 lacking its extracel-
lular domain, designated CA-LRP6, causes a potent Wnt signal
(Tamai et al., 2004) . CA-LRP6 cytoplasmic signalosome forma-
tion (Bilic et al., 2007) required Dynamin and caused a striking re-
localization of GSK3b from the cytosol into prominent cyto-
plasmic puncta (Figures 1G–1L0 and Figures S1D–S1O).
Treatment of 3T3 cells with LysoTracker, a dye that becomes
concentrated in acidic organelles such as MVBs and lysosomes,
showed that endogenous GSK3b relocated to these compart-
ments (Figure 1G–1L0). In addition, GSK3b colocalized with Dvl,
Axin, and LysoTracker, as well as the PI3P probe FYVE-GFP,
when Wnt signaling was activated by overexpression of Dvl
(Figures S2A–S2O). Remarkably, a protein consisting of the
DIX domain of Dvl fused to the LRP6 cytoplasmic tail (DIX >
Ctail-GFP), which triggers a very strong Wnt signal (Metcalfe
et al., 2010), also formed signalosomes colocalizing with acidic
vesicles that sequestered cytosolic GSK3b (Figures S2P–S2Aa).
CA-LRP6 signalosomes colocalized with the late endosomal
marker Rab7-GFP (Figures 1M–1R) in 62% ± 7% of the GSK3
puncta, indicating that GSK3-RFP relocated to MVBs or lyso-
somes (Bucci et al., 2000). About 40% of GSK3-RFP vesicles
colocalized with Vps4-GFP (see Figures 3L–3N0), a marker of
the final stages of intralumenal vesicle formation in endosomes
(Bishop and Woodman, 2000; Gruenberg and Stenmark, 2004).
In untransfected 3T3 cells the number and size of endogenous
GSK3b puncta increased after treatment withWnt3a conditioned
medium (Figures 1S–1U) in cells permeabilized with Digitonin
(which facilitates the visualization of intracellular organelles;
Bishop and Woodman [2000]).
Taken together, these results strongly support the hypothesis
that Wnt signaling causes the relocalization of cytosolic GSK3 to
the endosomal compartment.GSK3 Is Sequestered inside MVBs
To determine whetherWnt3a treatment sequesters GSK3 kinase
activity from cytosol, endogenous cytosolic kinase activity was
measured in untransfected L cells permeabilized with Digitonin
through the incorporation of phosphate from [g32P]-ATP into
a phospho-glycogen synthase peptide substrate (Ryves et al.,
1998). Digitonin solubilizes cholesterol-rich patches in the
plasma membrane, leaving MVBs and other intracellular organ-
elles intact (Dunn and Holz, 1983). Addition of Wnt3a for 4 hr
decreased cytosolic GSK3 activity levels by 66% ± 5% (Fig-
ure 2A, lanes 1 and 2), and the missing GSK3 activity was recov-
eredwhen all membraneswere dissolvedwith 0.1%Triton X-100
(Figure 2A, compare lanes 2 and 4).
The gold standard to determine the localization of a protein
inside a membrane-bounded compartment is the protease
protection assay. GSK3 protein became protected from
Proteinase K digestion (Vanlandingham and Ceresa, 2009) after
Wnt3a treatment (Figure 2B, compare lanes 3 and 4) in untrans-
fected L cells permeabilized with Digitonin. This Wnt-dependent
protease protection of GSK3 was eliminated when membranes
were solubilized with 0.1% Triton X-100 (Figure 2B, lanes 4
and 6). As a negative control, we used a-tubulin, which is not
contained in vesicular organelles and was not protected from
Proteinase K digestion (Figure 2B). These experiments stronglyell 143, 1136–1148, December 23, 2010 ª2010 Elsevier Inc. 1137
Figure 1. GSK3b Is Translocated to Acidic Vesicles upon Wnt Signaling
(A–F) In coculture experiments, xWnt8-Venus (green) secreted by 293T cells caused the relocalization of GSK3b-RFP (red) in 3T3 cells that endocytosed Wnt.
Arrows in the enlargement in (F) indicate xWnt8-Venus endosomes that sequester GSK3-RFP. In controls lacking xWnt8-Venus, GSK3-RFP localizationwas cyto-
plasmic (D and E); asterisks indicate untransfected control 293 cell nuclei.
(G–L0) GSK3b antigen relocalized to LysoTracker-positive endosomes upon activation of Wnt pathway by CA-LRP6 in 3T3 cells; note that endogenous GSK3b
was depleted from cytoplasm.
(M–R0) Rab7-GFP (green) and GSK3b-RFP (red) colocalized in CA-LRP6 signalosomes (in 62% ± 7% of GSK3-positive puncta, n = 80 HeLa cells); note GSK3
sequestration from cytosol.
(S–U) Endogenous GSK3b puncta (white) were larger and more numerous after 4 hr of Wnt3a addition to untransfected 3T3 cells permeabilized with Digitonin.
Data are represented as mean ± SEM. Also see Figure S1 and Figure S2.suggest that GSK3 becomes sequestered within membrane-
bounded organelles upon Wnt treatment.
The relocalization of GSK3 to multivesicular endosomes in
Wnt3a-treated cells was visualized by cryoimmunoelectron
microscopy. In untransfected 3T3 cells treated with control
conditioned medium, endogenous GSK3b was found almost
exclusively in the cytosol, whereas in Wnt3a-treated cells
a substantial fraction was found inside MVBs (Figures 2C and
2D). In HeLa cells cotransfected with CA-LRP6 and GSK3-
GFP, an anti-GFP antibody revealed colloidal Gold particles in
MVBs (Figure 2E). In some cases Gold particles were observed
on the cytoplasmic surface of vesicles fusing with multivesicular
endosomes (Figure 2F), as well as within the small vesicles that
fill MVBs (arrows with asterisks in Figure 2F), supporting the
topology shown in Figure 7. In the absence of CA-LRP6, Gold-
labeled GSK3-GFP was located in the cytosol (Figure 2G).
To confirm the cryoimmuno localization results in a quantitative
way, we resorted to an activated mutant of Rab5. Rab5-Q79L1138 Cell 143, 1136–1148, December 23, 2010 ª2010 Elsevier Inc.causes the formation of giantmultivesicular endosomes contain-
ing large numbers of intralumenal vesicles (Wegener et al., 2010).
These MVBs are so large that the outer membrane (outlined by
Rab5-QL-DsRed) can be readily distinguished from its internal
contents by light microscopy. As shown in Figures 2H–2M,
GSK3b translocated from the cytoplasm into the interior of
Rab5-QLmultivesicular endosomes (arrows, 77% ± 9%colocal-
ization) when CA-LRP6 was coexpressed, but not in its absence.
Cytosolic depletion of GSK3-GFP was very clear (compare
Figures 2J and 2M).
Taken together, these results demonstrate that the GSK3
enzyme becomes translocated from the cytosol into membrane-
bounded multivesicular endosomes when Wnt signals.
Wnt Signaling Requires the ESCRT Machinery
The molecular machinery that forms endosomal intralumenal
vesicles has been well characterized (Wollert and Hurley,
2010). Several endosomal sorting complexes required for
Figure 2. Wnt Signaling Causes Sequestration of GSK3 inside Multivesicular Endosomes
(A) GSK3 kinase activity was decreased by 66% ± 5% byWnt3a treatment and was recovered after membrane solubilization with 0.1% Triton X-100 in Digitonin-
permeabilized L cells. LiCl inhibition shows that the radioactive assay was specific for GSK3. Data are from two independent experiments using untransfected L
cells. GSK3b and a-tubulin provide loading controls.
(B) GSK3b becomes protected from Proteinase K after Wnt3a treatment, but only in the absence of Triton X-100 (lanes 3–6). Similar results were obtained in five
independent experiments (untransfected L cells). All samples were permeabilized with Digitonin, which causes leakage of 37% of the endogenous GSK3 (three
independent experiments).
(C andD) Cryoimmunoelectronmicroscopy demonstrating relocation of endogenous GSK3b intoMVBs (arrows) afterWnt3a treatment in untransfected 3T3 cells.
(E–G) GSK3-GFP localized in MVBs (white arrows) in CA-LRP6 transfected HeLa cells but was cytosolic in control cells lacking CA-LRP6 transfection.
(H–J) Rab5-QL-DsRed forms giant endosomes (arrows), whereas GSK3b-GFP remains uniformly distributed in the cytosol (n = 100).
(K–M) In the presence of CA-LRP6, GSK3-GFP is translocated inside Rab5-QL giantmultivesicular endosomes (see arrows) in 77% ± 9%, n = 80, of cotransfected
cells. Note that GSK3 becomes depleted from cytosol.
Data are represented as mean ± SEM.transport, or ESCRTs, have been identified through yeast
genetics (designated Vacuolar Protein Sorting, Vps, mutants)
and biochemistry (Katzmann et al., 2002). The GSK3 sequestra-
tion hypothesis predicts that ESCRT proteins essential for
vesicle invagination should be required for Wnt signaling. There-
fore, we tested two ESCRT proteins essential for vesicle forma-
tion (Figure 3A).
HRS/Vps27 (hepatocyte growth factor regulated tyrosine-
kinase substrate) initiates formation of the ESCRT-0 complex.CDepletion of HRS by siRNA blocked the accumulation of b-Cat-
enin observed after 2 hr of Wnt3a treatment in 293T cells,
whereas control scrambled siRNA had no effect (Figure 3B,
lanes 1–4). Total GSK3 levels increased by about 70% when
HRSwas depleted (Figure 3B compare lanes 1 and 3, three inde-
pendent experiments; see also Figure S3), suggesting that GSK3
is normally partially degraded by the endosomal machinery;
however, Wnt addition did not significantly change GSK3 levels
in these experiments. We were expecting a decrease in totalell 143, 1136–1148, December 23, 2010 ª2010 Elsevier Inc. 1139
Figure 3. Components of the ESCRT Machinery Are Required for Wnt Signaling
(A) HRS and Vps4 are proteins required for intralumenal vesicle formation in MVBs. GSK3 is indicated in red.
(B) HRS siRNA inhibits Wnt3a-induced accumulation of b-Catenin.
(C) TCF-Luciferase reporter gene assays showing that Wnt signaling requires HRS (brackets).
(D–E0) HRS is required for sequestration of GSK3-RFP in CA-LRP6 signalosomes (78% ± 8%, n = 150).
(F) Wnt signaling induced by CA-LRP6mRNA in Xenopus animal caps was blocked by HRS morpholino (brackets). (G–I) Induction of secondary axis in Xenopus
embryos by CA-LRP6 mRNA (80 pg) requires HRS (neural tissue visualized with Sox2 probe).
(J and K) Expression of Vps4-EQ, but not Vps-WT, inhibited signaling by Wnt3a or CA-LRP6 (brackets) in 293T cells.
(L–N0) CA-LRP6 signalosomes sequestered endogenous GSK3b and partly colocalized with Vps4-WT-GFP, a multivesicular endosome marker (43% ± 5% of
vesicles, arrows, in n = 80 cells).
(O–Q0 ) Overexpression of Vps4-EQ-GFP inhibits sequestration of endogenous GSK3b in CA-LRP6 signalosomes. (R–T) Head formation in axes induced by
CA-LRP6 was inhibited by Vps4-EQ, but not by Vps4-WT mRNA.
Data are represented as mean ± SEM. Also see Figure S3 and Figure S4.GSK3 levels in western blots becauseMVBs are usually targeted
to the lysosome and degradation. Many reasons might explain
this result. For example GSK3 may have a long half-life, it may
be replenished by translational regulation, or GSK3 may have
a long time of residency in MVBs induced by Wnt signaling
before lysosomal degradation takes place (Wnt might even
affect the rate of MVB processing globally). In addition there is1140 Cell 143, 1136–1148, December 23, 2010 ª2010 Elsevier Inc.recent evidence that intralumenal MVB vesicles may be recycled
back into the cytosol by ‘‘back-fusion’’ to the late endosome-
limiting membrane (Falguieres et al., 2009). Despite the lack of
change in total levels, the relocation of GSK3 from the cytosol
into MVBs is clearly documented in the figures above, providing
the basis for the sequestration model for Wnt signaling pre-
sented in Figure 7.
The requirement of HRS for Wnt signal transduction was
demonstrated directly in these cultures by measuring the
expression of the SuperTopFlash-Luciferase reporter, which
contains multiple TCF-binding sites (Figure 3C, brackets).
In addition we observed that relocalization of GSK3 into
vesicle-like structures in CA-LRP6 transfected cells was blocked
by HRS siRNA and was not affected by control scrambled siRNA
(Figures 3D–3E0). In animal cap explants the activation of
TCF-Luciferase by CA-LRP6 mRNA was blocked by HRS anti-
sense morpholino (Figure 3F, brackets). In Xenopus embryos,
injection of CA-LRP6 mRNA into a single ventral blastomere at
the eight-cell stage caused complete axis duplications, which
were eliminated by coinjection of HRS MO (Figures 3G–3I and
Figure S4N). HRS depletion did not affect cell viability or prolifer-
ation until neurula stage (Figures S4A–S4M). The effects of HRS
MOcould be partially rescued by humanHRSmRNA (Figures 4C
and 4O).
Vps4 is an ATPase required for the disassembly of ESCRT-III
complexes, the last step in the pinching off of intralumenal vesi-
cles in multivesicular endosomes (Gruenberg and Stenmark,
2004). A point mutation in the ATPase site (Vps4-EQ) creates
a potent dominant-negative form that inhibits MVB formation
(Bishop and Woodman, 2000). Vps4-EQ blocked canonical
Wnt3a signaling (Figure 3J, brackets). The control in this exper-
iment was Vps4-WT, which differs by only one amino acid yet
was without effect in TCF-Luciferase assays. Vps4-EQ also in-
hibited the transcriptional effects of CA-LRP6 (Figure 3K,
brackets). Vps4-EQ cotransfection inhibited the relocalization
of endogenous cytosolic GSK3b into CA-LRP6 signalosomes
(Figures 3L–3Q). In Xenopus embryos, Vps4-EQ, but not Vps4-
WT, coinjected with CA-LRP6 mRNA into a ventral blastomere
inhibited the formation of complete secondary axes containing
head structures (Figures 3R–3T and Figure S4O). Importantly,
we also tested the requirement of the ESCRT machinery for
axis induction by Siamois, a homeobox gene activated by Wnt
signaling. We found that Vps4-EQ mRNA was unable to inhibit
Siamois secondary axes (see Figures 4Ba–4Da and Figure S5A).
This epistatic experiment placed the requirement for Vps4 early
in the Wnt pathway, upstream of its transcriptional effector
Siamois.
These experiments show that two components of the ESCRT
machinery, HRS/Vps27 and Vps4, are required for canonical Wnt
signaling.
b-Catenin Is Required for GSK3 Sequestration
While investigating the requirements for GSK3 sequestration, we
made an unexpected finding: the translocation of GSK3 into
CA-LRP6 signalosomes and its depletion from the cytosol
were inhibited by b-Catenin siRNA (Figures 4A and 4B and Fig-
ure S3C). Using SuperTopFlash reporter in animal caps, we
found that HRS MO blocked signaling by microinjected b-Cate-
nin mRNA and was partially rescued by human HRS mRNA
coinjection (Figure 4C). We also noticed that endogenous b-Cat-
enin, especially its GSK3-phosphorylated form (i.e., targeted for
degradation), colocalized with CA-LRP6-GFP in signalosomes
(Figures 4D–4F). Taken together, these results suggest that
b-Catenin is required for the sequestration of GSK3 inmultivesic-
ular endosomes.CWe next asked whether b-Catenin overexpression was suffi-
cient to trigger GSK3 sequestration in endosomes. Stabilized
b-Catenin-GFP (in which its three GSK3 sites were mutated
into alanines) accumulated in the nucleus as expected but also
in cytoplasmic vesicle-like structures, which sequestered
GSK3-RFP (Figures 4G–4I). Wild-type b-Catenin-GFP accumu-
lated inside giant Rab5-QL MVBs (Figures 4J–4L) and in Lyso-
Tracker-positive vesicles (Figures S3D–S3F). Injection of b-Cat-
enin mRNA into a ventral cell causes twinning in Xenopus
embryos. Coinjection of b-Catenin mRNA with HRS-MO or
Vps4-EQ showed thatMVB formationwas required for b-Catenin
axis induction in Xenopus (Figures 4M–4R and Figures S4P and
S4Q).
This new function of b-Catenin in sequestering GSK3 in MVBs
occurs upstream of the well-established transcriptional role of
b-Catenin and Tcf3 in Wnt signaling (Clevers, 2006). Depletion
of b-Catenin with MO generated ventralized Xenopus embryos
lacking all neural structures (Figures 4S and 4T). Although
GSK3 inhibition by DN-GSK3b mRNA (a dominant-negative
catalytically inactive form) greatly expanded neural structures,
this effect was blocked by b-Catenin or xTcf3 depletion (Figures
4U–4W). However, a construct fusing the transactivation domain
of Xenopus b-Catenin to DN-xTcf3 was able to signal in b-Cate-
nin-depleted embryos (Figure 4X). In secondary axis induction
assays, the b-Catenin-DN-xTcf3 fusion was active even when
MVB formation was inhibited by Vps4-EQ mRNA microinjection
(Figures 4Y–4Aa and Figure S5B). These experiments show that
the classical transcriptional role of b-Catenin/Tcf3 is distinct
from its new function in facilitating GSK3 sequestration.
We conclude that b-Catenin protein is required and sufficient
to cause GSK3 sequestration in acidic cytoplasmic endosomes.
It has been proposed that the entire destruction complex (which
includes b-Catenin) is recruited to phosphorylated LRP6 recep-
tors (Zeng et al., 2008). Once b-Catenin levels begin to rise
during Wnt signaling, b-Catenin would enhance the signal, form-
ing a feed-forward loop by facilitating GSK3 sequestration.
Sequestration of GSK3 Regulates Protein Half-Life
Phosphorylation of b-Catenin or Smad1 by GSK3 causes recog-
nition by E3 polyubiquitin ligases and protein degradation (Logan
and Nusse, 2004; Fuentealba et al., 2007). To investigate
whether GSK3 sequestration causes the stabilization of other
proteins in addition to b-Catenin and Smad1, we first designed
computer algorithms to identify potential phosphate-primed
GSK3 sites in the human proteome (Figure 5A) and whether
they were evolutionary conserved. A large number of proteins
(20% of the proteome) were found to contain three or more
consecutive potential GSK3 sites (Table S1 and Table S3), signif-
icantly more than expected from random distribution (Table S1).
These included many novel putative GSK3 targets with known
regulatory functions (Table S2).
To determine whether Wnt/GSK3 signaling regulates overall
protein stability, we carried out radioactive pulse-chase experi-
ments with 35S methionine in untransfected 293T cells. Cultured
cells were radioactively labeled for 30 min, washed, and then
treated with Wnt3a or control conditioned medium containing
a 4-fold excess of unlabeled methionine. As shown in Figure 5B,
the total half-life of labeled cellular proteins increased from 9.3 toell 143, 1136–1148, December 23, 2010 ª2010 Elsevier Inc. 1141
Figure 4. b-Catenin Is Required for GSK3 Localization in Multivesicular Endosomes
(A and B) b-Catenin siRNA inhibited GSK3b relocalization in CA-LRP6 signalosomes (in 86% ± 7% of transfected HeLa cells, n = 300).
(C) HRSMOblocks the induction of TCF reporter expression (brackets) by b-CateninmRNA (four injections of 80 pg) in Xenopus animal cap explants, and this was
partially rescued by human HRS mRNA.
(D–F0) Endogenous phospho-b-Catenin colocalizes with CA-LRP6-GFP signalosomes in HeLa cells (85% ± 3% of transfected cells, n = 56).
(G–I0) Overexpression of a stabilizedmutant of b-Catenin-GFP caused its accumulation both in the nucleus and in cytoplasmic particles that sequester GSK3-RFP
from the cytoplasm (75% ± 11%, n = 60).
(J–L0) Wild-type b-Catenin-GFP becomes localized inside giant endosomes induced by Rab5-QL-DsRed. Seventy-nine percent ± 10% of giant MVBs contained
b-Catenin-GFP, n = 80.
(M–O) Axis induction by b-Catenin mRNA (80 pg) in Xenopus was blocked by coinjection of HRS-MO and partially rescued by 10 pg human HRS mRNA.
(P–R) Vps4-EQ, but not Vps4-WT, mRNA inhibited secondary axis formation by b-Catenin mRNA.
(S–X) Nuclear function of b-Catenin in Xenopus embryos. Wild-type, but not b-Catenin depleted embryos, contains neural tissue marked by Sox2 (n = 44 and
n = 25). Microinjection of DN-GSK3 mRNA (150 pg, four times at four-cell) dorsalized in a b-Catenin dependent manner (n = 38 and n = 28). DN-Tcf3 mRNA
(200 pg, four times) blocked dorsalization by DN-GSK3 (n = 36), whereas the fusion construct b-Catenin-DN-xTcf3 (30 pg) rescued the ventralizing effects of
b-Catenin MO (n = 26). Arrowheads indicate position of the blastopore.
(Y–Aa) Epistatic experiment showing that b-Catenin-DN-xTcf3 fusion protein does not require MVB formation to induce secondary axes in Xenopus embryos.
(Ba–Da) Epistatic experiment showing that the downstream target of Wnt signaling Siamois is not affected by MVB inhibition.
Data are represented as mean ± SEM. Also see Figure S5.11.8 hr in Wnt3a medium. Electrophoresis and autoradiography
after 6 hr of cold chase showed that a wide range of proteins
were stabilized by Wnt treatment (Figure 5C, lanes 1 and 2),
even when protein synthesis was inhibited with cycloheximide
(Figure 5C, lanes 3 and 4; Figure S6A). Thus, the effect of Wnt1142 Cell 143, 1136–1148, December 23, 2010 ª2010 Elsevier Inc.on radioactive protein stability is direct and not due to the
expression of genes activated after Wnt is added.
Wnt-stabilized proteins were detected mostly in the 35–
150 kDa range (Figures 5D and 5F). The stabilization of radioac-
tive proteins by Wnt was eliminated by depletion of b-Catenin
Figure 5. Wnt Prolongs the Half-Lives of Cellular Proteins via GSK3 Inhibition
(A) Twenty percent of human proteins contain three or more putative GSK3 sites primed by various kinases.
(B) Radioactive pulse-chase experiment showing that the half-life of total proteins was increased by Wnt3a treatment of 293T cells.
(C) Wnt3a treatment stabilized many proteins after 6 hr of chase in autoradiographs, even after inhibiting protein synthesis with cycloheximide (see Figure S6A);
Coomassie brilliant blue (CBB) staining provides equal loading control.
(D–H) b-Catenin was required for protein stabilization by Wnt3a. Densitometric tracings show that proteins stabilized by Wnt are within the 35–150 kDa range
(note m.w. standards).
(I–M) Depletion of GSK3a/b or their chemical inhibition by BIO resulted in protein stabilization similar to Wnt3a, whereas proteasomal inhibition by MG132 stabi-
lized a wider range of proteins than Wnt3a or GSK3 inhibition.
Also see Figure S6, Table S1, Table S2, and Table S3.with siRNA (Figures 5D–5H). This requirement for b-Catenin in
protein stabilization is explained by our finding that b-Catenin
is essential for the sequestration of GSK3 (Figure 4). Axin is
required for LRP6 signalosome formation and signaling (Bilic
et al., 2007) and also for overall protein stabilization by Wnt
(Figure S6F).
Protein stabilization by Wnt3a mimicked the effects of GSK3
inhibition. In 293T cells, depletion of GSK3a had little effect on
protein stability, but depletion of GSK3b, or GSK3a and b, stabi-
lized the same range of proteins as Wnt3a treatment (Figure 5I,
lanes 1–5). A chemical inhibitor of GSK3, BIO, caused a similar
stabilization, whereas the proteasome inhibitor MG132 gener-
ated a different profile in which proteins below the 35 kDa range
were also strongly stabilized (Figures 5I–5M). Thus, althoughWnt
signaling stabilized many proteins, these represented only
a subset of the total proteome.
These results suggest thatWnt signaling andGSK3 activity are
regulators of the half-life of many cellular proteins. Some of the
novel putative GSK3 targets listed in Table S2, HDAC4 andCJunB, were tested and found to be stabilized by Wnt treatment
(Figures S6B–S6E). In addition the half-life of Smad4 was also
regulated by Wnt, resulting in increased TGFb signaling
(H. Demagny and E.M.D.R., unpublished data). Testing all
possible Wnt/GSK3 targets would be a daunting task, so we
took a different approach, generating an artificial protein that
serves as a biosensor of Wnt/GSK3activity.
A Reporter Protein for GSK3 Activity
What would be the effect of adding GSK3 sites to a protein that
lacked them? An artificial GFP construct was generated in which
three GSK3 sites primed by a canonical MAPK phosphorylation
site (PXSP) were added to its carboxy-terminus via a row of
alanines (Figure 6A). A Flag-tag and a PPAY site for the binding
of E3 polyubiquitin ligases of the HECT family (mimicking
Smad1; Fuentealba et al. [2007]) were also added. The HECT
E3 ligase site helped but was not essential (Figure S7B); even
in its absence, the biosensor protein could be destabilized by
another E3 ligase, bTrcp (Figure S7C).ell 143, 1136–1148, December 23, 2010 ª2010 Elsevier Inc. 1143
Figure 6. A Wnt-Regulated Reporter Protein Generated by Introducing Multiple GSK3 Phosphorylation Sites
(A and B) Sequences of the GFP-GSK3-MAPK biosensor construct and its GSK3 phosphorylation-resistant mutant. This protein is predicted to be primed by
MAPK/Erk and further phosphorylated by GSK3.
(C) Western blot showing stabilization of GFP-GSK3-MAPK and endogenous b-Catenin by Wnt3a treatment (6 hr) or DN-GSK3 transfection in transfected 3T3
cells. a-Tubulin served as loading control.
(D) When GSK3 sites were mutated, GFP was stabilized and did not respond to Wnt.
(E–H) GFP fluorescence in 3T3 cells transfected with GFP reporter proteins. Note that fluorescence was increased byWnt3a treatment or mutation of GSK3 sites.
Also see Figure S7.Cells were transfected with GFP-GSK3-MAPK construct, split
into two cultures, and treated with control or Wnt3a conditioned
medium for 6 hr. The GFP-GSK3-MAPK reporter protein was
stabilized by Wnt3a treatment (Figure 6C, compare lanes 2 and
3,Figures 6E and 6F). Remarkably, the degree of stabilization
of this biosensor protein was comparable to that of endogenous
b-Catenin, whereas a-tubulin remained unchanged (Figure 6C).
The stabilization caused by Wnt could be mimicked by cotrans-
fection of DN-GSK3 (Figure 6C, lane 4) or by treatment with the
GSK3 inhibitor BIO (data not shown). To demonstrate that stabi-
lization by Wnt indeed occurred at a posttranslational level, we
mutated the GSK3 sites into alanines, generating GFP-
GSK3mut-MAPK (Figure 6B). This GSK3 phosphorylation-resis-
tant protein became stabilized and was no longer affected by
Wnt3a treatment (Figures 6D, 6G, and 6H). Thus, the presence
of GSK3 phosphorylation sites is sufficient to destabilize GFP.
The type of priming kinase was not critical because constructs
primed by CK1 were similarly stabilized by Wnt (Figure S7E).
These studies with a GFP reporter protein indicate that
multiple consecutive GSK3 phosphorylation sitesmake a protein
less stable, presumably by favoring recognition by E3 polyubi-
quitin ligases of the bTrcp or HECT types (Logan and Nusse,
2004; Fuentealba et al., 2007). The results indicate that Wnt
signaling is able to deplete GSK3 from the cytosol to levels low
enough to stabilize a biosensor of cellular GSK3 activity.1144 Cell 143, 1136–1148, December 23, 2010 ª2010 Elsevier Inc.Because the proteome contains a multitude of GSK3 phosphor-
ylation targets, we expect that canonical Wnt signaling will have
many previously unsuspected metabolic effects.
DISCUSSION
We investigated the cellular mechanism by which Wnt signaling
causes GSK3 inhibition. The results support a new model for
canonical Wnt signal transduction, in which the GSK3 enzyme
becomes sequestered inside multivesicular endosomes trig-
gered by activation of the Frizzled and LRP6 receptors,
decreasing GSK3 levels in the cytosol (Figure 7). The key insight
that led to the GSK3 sequestration hypothesis was the realiza-
tion that during the normal endocytosis process, early endo-
somes containing activated receptors are packaged within
multivesicular endosomes (McKanna et al., 1979; Katzmann
et al., 2002; Gruenberg and Stenmark, 2004). GSK3 is recruited
to the cytoplasmic side of Wnt receptor complexes and phos-
phorylates LRP6 and other substrates such as Dvl, APC,
Axin, and b-Catenin (MacDonald et al. [2009]; Table S2), to
which it normally binds. The key to transcriptional activation
by Wnt signaling is the nuclear accumulation of b-Catenin.
Although b-Catenin protein initially translocates into MVBs
together with GSK3, once cytosolic levels of GSK3 are
sufficiently depleted, newly translated b-Catenin is not
Figure 7. Model of Canonical Wnt Signaling
through the Sequestration of GSK3 inside
Multivesicular Endosomes
Binding of GSK3 (in red) to the Wnt receptor
complex (including phospho-LRP6, phospho-b-
Catenin, and other GSK3 substrates such as Dvl,
Axin, and APC) sequesters GSK3 inside small in-
tralumenal MVB vesicles, causing its cytosolic
substrates such as b-Catenin (in blue) and many
other proteins to become stabilized (see text).
The initial GSK3 molecules are recruited to the
receptor complex bound to Axin, ensuring that
the GSK3 fraction bound to the destruction
complex is depleted first. Diagram modified from
Zeng et al. (2008).phosphorylated and becomes stabilized, accumulating in the
nucleus. Many cellular proteins contain putative GSK3 phos-
phorylation sites (Table S3) and are also candidates for stabili-
zation by canonical Wnt signaling.
GSK3 Is Relocalized into MVBs upon Wnt Signaling
The results strongly support the GSK3 sequestration hypothesis,
providing a solution to the long-standing question of how GSK3
activity is inhibited by Wnt. In coculture experiments, GSK3
accumulated in endosomes containing endocytosed xWnt8-
Venus and was depleted from the cytosol. Protease protection
studies showed that Wnt3a treatment causes the relocalization
of GSK3 inside membrane-bounded organelles. These corre-
sponded to MVBs in cryoimmunoelectron microscopy. Remark-
ably, Wnt pathway activation by overexpression of CA-LRP6,
Dvl, or of Dvl DIX > Ctail construct (Tamai et al., 2004; Capelluto
et al., 2002; Metcalfe et al., 2010) relocalized GSK3 into acidic
endosomes, decreasing levels of this enzyme in cytosol (Figure 1
and Figure S2). We also observed reductions in cytosolic GSK3
by addition of Wnt3a protein acting on its endogenous receptors
(Figures 1A–1C, 1S–1U, Figures 2A–2D, Figures 3B and 3C, Fig-
ure 5, and Figure 6; Figures S1A–S1C). Finally, two components
of the molecular ESCRT machinery required for the formation of
MVBs, HRS and Vps4, were shown to be essential for canonical
Wnt signaling in TCF transcriptional reporter and Xenopus
embryo essays. In epistatic experiments, ESCRT activity wasCell 143, 1136–1148, Denot required for axis induction by Sia-
mois, a transcriptional target down-
stream of Wnt signaling.
How does this GSK3 sequestration
model fit in with the present state of
knowledge concerning Wnt signaling?
Receptor internalization is required for
Wnt to signal (Blitzer and Nusse, 2006;
Yamamoto et al., 2006). The proportion
of Frizzled receptor destined for degrada-
tion versus recycling back to the
membrane is regulated by a ubiquitinyla-
tion/deubiquitinylation cycle (Mukai et al.,
2010), a process that was not investi-
gated here. Bilic et al. (2007) found that
aggregates containing Dvl, phosphory-lated LRP6, Axin, and GSK3 are induced by Wnt treatment.
Designated as LRP6-signalosomes, these aggregates are very
prominent in cells in which the Wnt pathway is activated by
CA-LRP6, Dvl, or DIX-Ctail overexpression (Bilic et al., 2007,
Metcalfe et al., 2010). LRP6-signalosomes were proposed to
provide a platform for Wnt signaling on the cytosolic side of early
endosomes. The requirement for HRS and Vps4 reported here
demonstrates that Wnt signaling requires the formation of multi-
vesicular endosomes (Katzmann et al., 2002; Gruenberg and
Stenmark, 2004). There is no contradiction between the
LRP6-signalosome model and our results. Sequestration of
GSK3 in MVBs is not alone responsible for Wnt signaling. In
the early steps of the process, formation of a vesicular platform
facing the cytosol recruits the various components to the plasma
membrane and early endosomes. In the presence of DN-Dyna-
min, GSK3-RFP strongly accumulates in the plasma membrane
when Wnt signaling is activated (Figure S1F), although Wnt
signaling does not take place (Blitzer and Nusse, 2006). Wnt
signaling requires the completion of the next step in the endo-
cytic process. Once the neck of the intralumenal vesicles of
MVBs is closed, GSK3 will be prevented from equilibrating with
the cytosol, explaining why Wnt signaling requires a functional
ESCRT machinery.
There is a discrepancy between the requirement of HRS in
Wnt signaling described here and studies with HRS mutants
in Drosophila. Seto and Bellen (2006) reported enhancedcember 23, 2010 ª2010 Elsevier Inc. 1145
expression of Wg target genes in HRS clones (proposed to be
due to decreased lysosomal degradation of Wg), although other
authors reported no differences (compared towild-type tissue) in
similar clones (Rives et al., 2006). Perhaps in Drosophila some
degree of MVB formation is still achieved in the absence of
HRS through redundancy in the ESCRTmachinery. In the studies
presented here, we obtained significant inhibition of canonical
Wnt signaling with HRS siRNA, HRS MO, and Vps4-EQ, both
in cultured cells and in vivo in Xenopus.
Our observations help understand the paradoxical positive
and negative effects of GSK3 in early Wnt signaling (Zeng
et al., 2008). GSK3 phosphorylation of LRP6 initiates Wnt
signaling (MacDonald et al., 2009; Niehrs and Shen, 2010), yet
genetic and pharmacological studies show that GSK3 inhibition
is sufficient to trigger the canonical Wnt signal (Logan and
Nusse, 2004). The sequestration hypothesis helps resolve these
apparently contradictory functions, for LRP6 phosphorylation by
GSK3 not only initiates signaling but also causes the sequestra-
tion of GSK3 from the cytosol.
The key to canonical Wnt signaling is GSK3 inhibition, which
results in b-Catenin stabilization (Kimelman and Xu, 2006;
Wu and Pan, 2010). Several studies have shown that phosphor-
ylated LRP6 intracellular domain can inhibit GSK3 activity (Mi
et al., 2006; Cselenyi et al., 2008; Piao et al., 2008; Wu et al.,
2009), although with low affinity (Ki in the 10
5 M range).
However, GSK3 inhibition has been difficult to demonstrate bio-
chemically. One exception was a study using hypotonic cell
lysis, which reported a transient 40% decrease in GSK3 activity
that peaked 10 min after Wnt addition (Ding et al., 2000). This
early inhibition is likely explained via direct binding of GSK3 to
phospho-LRP6. However, this decrease in GSK3 activity disap-
peared after 1 hr (Ding et al., 2000), whereas stabilized b-Catenin
protein continues to accumulate for at least 6 hr after Wnt treat-
ment (Blitzer and Nusse, 2006). We now found that Wnt3a treat-
ment reduced cytosolic GSK3 activity levels by 66% after 4 hr of
Wnt3a addition in cells permeabilized with Digitonin (Figure 2A).
Wnt signaling requires the sustained inhibition of GSK3,
which is achieved by sequestration inside MVBs. The initial
recruitment of the destruction complex (Zeng et al., 2008)
would ensure that the GSK3 responsible for b-Catenin degra-
dation is depleted first (explaining in part the insulation from
other signaling pathways), followed by other cytosolic GSK3
molecules that bind to additional phosphorylated docking sites
provided by GSK3 phosphorylation sites in LRP6, Axin, b-Cat-
enin, Dvl, and APC (Jope and Johnson, 2004; Table S2). Thus,
although GSK3 is in stoichiometric excess to Axin, there are
many additional potential GSK3 binding sites present in the
Wnt receptor-signaling complex (Figure 7). Catalytically inactive
DN-GSK3b is not concentrated in MVBs (compare Figures S1G
and S1M), suggesting that GSK3 accumulates in MVBs
because it binds to its own substrates. Conversely, a GSK3
form that does not bind Axin but is catalytically active can accu-
mulate in LRP6 signalosomes (Figures S1J–S1L), demon-
strating that GSK3 molecules not directly associated with the
Axin destruction complex can still be sequestered by Wnt
signaling. By binding to its own substrates, GSK3 can be
depleted from cytosol even when Axin levels are stoichiometri-
cally lower.1146 Cell 143, 1136–1148, December 23, 2010 ª2010 Elsevier Inc.Did precedents for a role for theMVB pathway inWnt signaling
exist in the literature? Early on, van den Heuvel et al. (1989) re-
ported that endocytosed Wg accumulates in the MVB matrix in
cells responding to the Wg signal in Drosophila blastoderm.
Acidification by vacuolar/H+-ATPase is required for canonical
Wnt signaling (Cruciat et al., 2010). Dvl overexpression triggers
a canonical Wnt signal, and it was reported that this activity
correlated with its colocalization with phospholipids in vesicular
membranes via its DIX domain (Capelluto et al., 2002). Recently,
a fusion protein between the Dvl DIX domain and the Ctail of
LRP6 was found to be a very potent activator of Wnt signaling
(Metcalfe et al., 2010). Dvl and DIX > Ctail form signalosomes
that were initially interpreted as cytoplasmic protein aggregates.
However, as shown in Figure S2, the Dvl and DIX > Ctail particles
colocalized with FYVE-GFP (a PI3P marker) and also with the
acidic dye LysoTracker. These endosomal vesicles depleted
GSK3 from the cytoplasm. Their effect was specific because
point mutations in the DIX domain (Metcalfe et al., 2010) pre-
vented colocalization with LysoTracker and GSK3. Moreover, in-
hibiting MVB formation prevented induction of a TCF-Luciferase
reporter by the Dvl DIX/LRP6 fusion protein (Figure S2Ba). In
conclusion, previous observations were consistent with a role
for membrane vesicles in Wnt signaling, but their identity as
MVBs that sequester GSK3 was not recognized.Wnt Is a Regulator of Protein Catabolism
An unexpected finding was that Wnt prolongs the overall rate of
cellular protein degradation (Figure 5). The addition of three
consecutive GSK3 sites was sufficient to convert GFP into
a Wnt-responsive protein (Figure 6). Thus, cytosolic levels of
GSK3 are sufficiently depleted by Wnt treatment to stabilize
other proteins in addition to b-Catenin. Thus, GSK3 emerges
as a protein kinase with a central role in regulating protein
catabolism.
Bioinformatic analyses showed that about 20% of the human
proteome contains three or more possible primed GSK3 sites,
suggesting that many putative Wnt-regulated proteins exist.
Theprincipal transcriptional output ofWnt signaling is the interac-
tion between TCF/LEF and b-Catenin (Clevers, 2006). However,
many additional transcription factors interact with b-Catenin
(reviewed by MacDonald et al., 2009; see their Table S1). It is
intriguing that some of the proteins potentially stabilized by Wnt
in our list (Table S2) also interact with b-Catenin (e.g., FoxO,
HIF1a, Mitf, RAR). Therefore,Wnt signalingmay have unforeseen
regulatory complexities. Although Wnt signaling can crosstalk
with other signal transduction pathways in which GSK3 phos-
phorylations are involved, such as the BMP/Smad1 pathway
(Fuentealba et al., 2007), insulation between pathways is also
necessary. The degree of insulation will depend on the relative
affinities of the various substrates and their resistance to
decreases in levels of free GSK3. In addition crosstalk versus in-
sulation will depend on the type (and activity level) of priming
kinase used by the various signaling pathways. The effect of
Wnt on overall protein half-life had an absolute requirement for
b-Catenin (Figure 5I). This is likely explained by the finding that
b-Catenin is required, and its overexpression sufficient, for
GSK3 sequestration in MVBs (Figure 4).
Our findings indicate that canonical Wnt provides a signal in-
structing cells to slow down degradation of many proteins. The
recent discovery that LRP6 is phosphorylated at G2/M phase
independently of Wnt (Davidson et al., 2009) suggests that the
half-life of a multitude of GSK3 target proteins could be under
cell cycle control. The list of putative GSK3/Wnt targets identified
by our proteomic analyses suggests that Wnt/GSK3 signaling
may have wide metabolic effects. In addition it provides a rich
resource for discovering possible novel nodes of signaling
pathway integration (Table S3).A Positive Role for Endocytosis in Signal Transduction
Targeting ofmembrane receptors toMVBs and lysosomes nega-
tively regulates signaling by many growth factor receptors
(McKanna et al., 1979; Katzmann et al., 2002). A possible posi-
tive role for multivesicular endosomes in the release of Notch
intracellular domain to the nucleus has been reported (Coumail-
leau et al., 2009). In the case of canonical Wnt, the positive role of
endosomal trafficking is of a different nature because it is the
sequestration of GSK3 in MVBs that generates the signal (Fig-
ure 7). This raises the question of whether other plasma
membrane receptors might use multivesicular endosomes to
sequester proteins bound to their cytoplasmic tails. In this
view, specific intracellular proteins could be targeted to MVBs
in a growth factor-dependent manner. All eukaryotic cells
contain an elaborate ESCRT machinery that generates multive-
sicular endosomes. Further studies on how the cell biology of en-
docytic trafficking intersects with signaling by Wnt and other
growth factors may have implications for understanding human
disease, including cancer.EXPERIMENTAL PROCEDURES
DNA Constructs and siRNAs
The following GFP or RFP fusion proteins were generated for this study: GSK3-
RFP, GSK3-GFP, DN-GSK3-GFP, CA-LRP6-GFP, xDvl-RFP, stabilized
mutant b-Catenin-GFP, human HRS-RFP, GFP-GSK3-MAPK reporter, GFP-
GSK3mut-MAPK, GFP-GSK3-MAPK-E3mut, and GFP-GSK3-CK1-E3.
A pCS2 vector containing amino-terminal Flag-EGFP (GB#U55763) or HA-
RFP (GB#AF506027) was used to clone in-frame fusions generated by PCR
from ESTs or from constructs generously provided by colleagues listed in
the Acknowledgments. The siRNAs targeting human b-Catenin, HRS, and
Axin1 were ON-TARGETplus SMARTpool from Thermo Scientific
#L-003482, #L-016835, and #L-009625, respectively. The siRNAs used to
knock down human GSK3a and GSK3b were Validated Stealth RNAi DuoPak
from Invitrogen #45-3210 and #45-1488, respectively.Immunostaining and Western Blots
For immunostainings, primary antibodies were: anti-GSK3b monoclonal (BD
Transduction #610201) at 1:350, and anti-phospho-b-Catenin (Cell Signaling
#9561) at 1:350. For cryoimmunoelectron microscopy, antibodies used were
chicken IgY anti-GSK3b (Sigma #GW22779) at 1:800 and chicken IgY anti-
GFP (Invitrogen #A10262) at 1:250. For western blots, primary antibodies
used were the anti-GSK3b monoclonal at 1:1000, anti-b-Catenin (Sigma
#C2206) at 1:4000, anti-a-tubulin monoclonal (Calbiochem #CP06) at
1:1500, anti-Flag monoclonal (Sigma #F1804) at 1:1500, and anti-Total-Erk
(Cell Signaling #9102) at 1:1000. Secondary antibodies coupled to Infra Red
Dyes (IRDye 680 and IRDye 800) at 1:3000 (LI-COR) were used, and western
blots were analyzed using a LI-COR Odyssey scanner system.CStatistics
Results are given as the mean ± standard error of the mean (SEM). Statistical
analyses were performed with Excel (Microsoft Corp.) applying the two-tailed t
test, as appropriate. Differences of means were considered significant at
a significance level of 0.05.
Additional Methods
Detailed methods for cell culture, immunostainings, GSK3 enzyme activity
measurements, protease protection, cryoimmunoelectron microscopy, Xeno-
pus embryo assays, bioinformatic proteomic analyses, and radioactive pulse-
chase experiments are provided in Extended Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and three tables and can be found with this article online at doi:10.
1016/j.cell.2010.11.034.
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